Gilead Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GILD34.SA | LLY.NE | GLAXO.BO | BMY | BIIB | SNY | |
|---|---|---|---|---|---|---|
| Market cap | 1.19T | 1.74T | 424.73B | 131.21B | 37.61B | 113.74B |
| P/E (TTM) | — | 65.7 | 44.5 | 14.2 | 110.2 | 23.6 |
| Forward P/E | — | — | 37.0 | 9.6 | 15.6 | 8.9 |
| Price/book | 18.2 | 1.4 | 24.9 | 5.6 | 2.0 | 1.4 |
| Dividend yield | 1.29% | 0.58% | 1.75% | 3.93% | — | 5.10% |
| 1-year change | +43.23% | +35.37% | +6.17% | +32.80% | +62.24% | −7.49% |
| Today | +3.33% | +0.78% | −1.00% | +4.02% | +2.22% | +4.72% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All GILD34.SA news ›Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock investors acquired 16,499 put options on the company. This represents an increase of approximately 107%…
Gilead Sciences (GILD) Receives a Buy from Morgan Stanley
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades. In a report released today, Terence Flynn from Morgan Stanley assigned a Buy rating to Gilead Sciences, with a price target…
Gilead Sciences (GILD) Receives a Rating Update from a Top Analyst
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades. TD Cowen analyst Tyler Van Buren maintained a Buy rating on Gilead Sciences today and set a price target of $175.00. Van…
Gilead Sciences, Inc. $GILD Stock Holdings Lifted by BOCHK Asset Management Ltd
Read Our Latest Analysis on GILD GILD opened at $170.33 on Tuesday. Gilead Sciences, Inc. has a 12 month low of $116.88 and a 12 month high of $175.65. The company has a debt-to-equity ratio of 2.03, a quick ratio of 1.09 and a current…
What Is Drawing Attention Toward Gilead Sciences (NASDAQ:GILD) Today?
Can Sempra (NYSE:SRE) Sustain Its Momentum Across Utility Stocks? Market watchers have framed the company as the dominant force in HIV medicine, a position the prevention franchise aims to deepen. That framing has kept the stock near the…
Gilead Sciences, Inc. $GILD Stock Sold by Hennessy Advisors Inc.
MarketBeat Gilead Sciences, Inc. $GILD Stock Sold by Hennessy Advisors Inc. - Hennessy Advisors reduced its Gilead Sciences position by 21.6% in the third quarter, selling 18,399 shares and retaining 66,800 shares valued at approximate
More from 1 other outlet
Gilead Sciences declares $0.82 dividend
Gilead Sciences declares a $0.82 quarterly dividend with a 1.92% forward yield. - Gilead Sciences (GILD) declares $0.82/share quarterly dividend, in line with previous. - Payable Dec. 30; for shareholders of record Dec. 15; ex-div Dec. 15.
GILEAD SCIENCES ($GILD) Releases Q3 2026 Earnings, Stock Rises
GILEAD SCIENCES ($GILD) posted quarterly earnings results for Q3 2026 on Thursday, October 29th. The company reported earnings of $2.55 per share, beating estimates of $2.24 by $0.31. The company also reported revenue of $8,300,000,000,…
Gilead Sciences, Inc (Derivatives) priceGILD#7859
Gilead Sciences, Inc (Derivatives) price today, GILD to USD live price, marketcap and chart CoinMarketCap The live Gilead Sciences, Inc (Derivatives) price today is $171.11 USD with a 24-hour trading volume of not available. We update our…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com28
- marketbeat.com15
- defenseworld.net6
- stocktitan.net6
- seekingalpha.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 116 articles, not a forecast.